M. A. Hayat – Methods of Cancer Diagnosis, Therapy, and Prognosis (8 Volume set)

Описание

1. This is the first book that discusses subjects of diagnosis, therapy, therapy assessment, and prognosis of breast cancer in one single volume.
Cancer killed 6.7 million people around the world in 2002 and this figure is expected to rise to 10.1 million in 2020. Approximately, 189,510 new cases of breast cancer were reported in 2007 in the United States, and 40,910 died in the same year.
Focusing on Breast Carcinoma, this first volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis brings together 56 leading scientists from around the world to deliver a comprehensive treatise on all aspects of breast cancer, including diagnosis, treatments and prognosis. Scientists and clinicians have contributed state of the art chapters on their respective areas of expertise providing the reader a whole field view of breast cancer management.
This fully illustrated volume:
Presents a constructive evaluation of commonly used methods for elucidating primary and secondary cancer initiation, progression, relapse, and metastasis.
Highlights methods of breast cancer diagnosis and treatment assessment including various imaging modalities such as ultrasound, computed tomography, magnetic resonance imaging, immunohistochemistry and histochemistry.
Discusses detailed therapeutic protocols, including both their benefits and side-effects.
Discusses examples of breast cancer treatments includingchemotherapy, radiation, chemoradiation, surgery, hormonal – and immunotherapy
Details the molecular processes that lead to the development and proliferation of cancer cells
Includes recent major advances in cancer diagnosis and therapy assessment
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editinga must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

2. This second volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis presents a comprehensive treatise on all aspects of Lung and Prostate cancer, including diagnosis, treatments and prognosis. Scientists and Clinicians have contributed state of the art chapters on their respective areas of expertise providing the reader a whole field view of lung and prostate cancer management.
This fully illustrated volume
Discusses diagnosis using molecular genetics, various imaging
modalities, tumor markers and tumor gene therapy
Discusses treatments such as chemotherapy, radiation, chemoradiation, hormonal therapy, immunotherapy, and surgery; and prognosis
Highlights both primary and secondary cancers, and explains the risk of cancer survivors developing other cancers.
Attempts to translate molecular genetics into clinical practice. Evidence-based therapy is included.
Discusses the role of histology and immunohistochemistry in differentiating between pleuropulmonary desmoid tumors and solid fibroustumors.
Discusses cancer stem cells, mutations, cancer vaccines, and personalized cancer medicine

3. This third volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses diagnosis, therapy, and prognosis of Gastrointestinal Cancers. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume
Includes various aspects of esophageal cancer, gastric cancer, and pancreatic cancer
Highlights the methodologies used for diagnosis, therapy, and prognosis of these different cancers
Explains the molecular mechanisms underlying these cancers
Discusses the evaluation of FDG-PET/CT fusion imaging, endoscopic ultrasound and imaging, and the role of microRNA in prognosis
Details the classification of colon and gastric histological samples
Highlights treatments, including radiofrequency ablation and surgical debulking, endoscopic submucosal dissection, laparoscopic gastrectomy of gastric cancer and pancreaticoduodenectomy
Reviews use of radiotherapy and chemotherapy for pancreatic cancer patients
Discusses a large number of imaging modalities for diagnosing these cancers and assessing the different treatments

4. This fourth volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses various methodologies for the diagnosis, therapy and prognosis of Colorectal Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume:
Presents surgical, radiological, and molecular therapies and prognostic markers for colorectal cancer.
Highlights a large number of methods for diagnosing colorectal cancer at various stages of development, including immunohistochemistry, in situ hybridization immunoscintigraphy, RT- PCR, free circulating DNA levels in blood and stool, ultrasonography, CT, PET, and MRI.
Includes imaging technologies for assessing treatment results, and details related to colonoscopy and sigmoidoscopy.
Explains the use of anticancer agents and monoclonal antibodies, including 5-fluorouracil, fluoropyrimidines, leucovorin, irinotecan, oxaliplatin, raltitrexed, capecitabine, cetuximab, and bevacizumab.
Compares preoperative chemoradiotherapy with postoperative chemoradiotherpy.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of colorectal cancer and other cancer types.

5. This volume presents a detailed survey of various methodologies related to diagnosis, therapy, and prognosis of liver cancer, including colorectal liver metastases and biliary tract carcinomas, while the already published Volumes 1, 2, 3, and 4 detail similar aspects of breast, lung, prostate, gastrointestinal, and colorectal cancer, respectively.
Surgical resection is the standard therapy for resectable liver disease, resulting in 5-year overall survival rates of 20–40%. One the other hand, the median overall survival of patients with unresectable liver metastases does not exceed 18–20 months, with a 5-year survival rate approaching zero. In other words, there is virtually no long-term survival. Both resectable and unresectable liver cancers are discussed in this volume. The method of selecting patients for resection of hepatic colorectal metastases is explained. The type of chemotherapy used for surgically unresectable liver cancer is also presented.
In the current volume, attention is also given to the role of molecular genetics and biomarkers in the initiation and progression of liver cancer. The application of a variety of imaging modalities, including PET, SPECT, MRI, radial magnetic resonance imaging, multidetector-row computed tomography, helical computed tomography, ultrasonography, and power Doppler ultrasound, for the prognosis and assessment of liver cancer treatment (including HCC) and liver metastases from colorectal cancer are discussed in detail, as is the use of radiofrequency ablation in hepatic tumors.

6. This sixth volume in the series Methods of Cancer Diagnosis, Therapy, and Prognosis discusses Ovarian Cancer, Renal Cancer, Urogenitary Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included.
This fully illustrated volume
Identifies biomarkers based on genetic alterations for clear cell ovarian adenocarcinoma.
Identifies subgroups of ovarian cancer by using differential gene expression.
Includes the application of the power-Doppler imaging for distinguishing benign from malignant complex adrenal masses in ovarian cancer.
Emphasizes the advantage of using cytoreduction surgery for diagnosing advanced ovarian cancer.
Provides details on the treatment of kidney cancer with radiofrequency ablation, surgery, and chemotherapy.
Explains the use of immunohistochemistry for diagnosing adenomatoid tumor of the adrenal gland.
Discusses the chemotherapy of testicular cancer and related second primary tumors.
Includes the diagnosis of urothelial bladder cancer with urine-based tumor markers.
Explains the use of immunohistochemistry and MRI for diagnosing uterine cervical cancer and describes the staging of this cancer using PET alone or PET/CT.
Describes the localization of malignant melanoma using FDG-PET/CT.
Explains the use of prognostic receptors for nonmelanoma skin cancer.
Details the treatment of multiple myeloma using immunotherapy, radiotherapy, and targeted radionuclide therapy.
Presents diagnostic immunohistochemistry of synovial and Kaposi’s sarcoma.
The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of these different types of cancer.
Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

7. The seventh volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses General Methods, Overviews, Head and Neck Cancer, and Thyroid Cancer. As in the other six volumes of the series, these subjects are discussed in detail.
This fully illustrated volume presents overviews in
Radio-immunotherapy in Cancer
Multidrug Resistance
Cancer Biomarkers
Role of Antibodies in Cancer Treatment
Classification of Cancer Stage Using Patient’s Immune System
Cancer Stem Cells
General methods discussed are
Translating In Vitro Cell Lines Result into Clinical Practice
Late Relapse of Germ Cell Malignancies
Role of RNA Interference in Understanding the Molecular Bases of Cancer
Incorporating Pharmacogenomics into Cancer Therapy
Tumor Angiogenesis in Cancer
Spindle Cell Oncocytoma of the Adenohypophysis
Chemotherapy-Induced Neurotoxicity
Disseminated Carcinoma of Unknown Primary Site
Unknown Lymphadenopathy

8. This eighth volume in the series Methods of Cancer Diagnosis, Therapy, and Prognosis discusses in detail the classification of the CNS tumors as well as brain tumor imaging. Scientists and Clinicians have contributed state of the art chapters on their respective areas of expertise, providing the reader a whole field view of the CNS tumors and brain tumor imaging in Europe. This fully illustrated volume: Explains the genetics of malignant brain tumors and gene amplification using quantitative-PCR; Presents a large number of standard and new imaging modalities, including magnetic resonance imaging, functional magnetic resonance imaging, diffusion tensor imaging, amide proton transfer imaging, positron emission tomography, single photon emission computed tomography, magnetic resonance single voxel spectroscopy and intraoperative ultrasound imaging, for staging and diagnosing various primary and secondary brain cancers; Explains the usefulness of imaging methods for planning and monitoring (assessment) therapy for cancers; Discusses diagnosis and treatment of primary CNS lymphomas, CNS atypical teratoid/rhabdoid and CNS Rosai-Dorfman disease; Includes the subject of translational medicine. Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.